acut
respiratori
distress
syndrom
ard
defin
associ
bilater
infiltr
hypoxaemia
follow
initi
insult
although
new
definit
recent
propos
berlin
definit
variou
form
ard
potenti
differ
regard
manag
ventil
set
prone
posit
use
corticosteroid
ard
caus
variou
aetiolog
adequ
treatment
respons
caus
crucial
improv
outcom
paramount
import
character
mechan
caus
lung
injuri
optim
aetiolog
treatment
symptomat
treatment
obviou
caus
ard
direct
lung
injuri
suspect
bronchoalveolar
lavag
bal
strongli
consid
identifi
microorgan
respons
pneumonia
blood
sampl
also
help
identifi
microorgan
evalu
biomark
infect
infecti
caus
ard
appar
aetiolog
found
secondlin
examin
includ
marker
immunolog
diseas
select
case
open
lung
biopsi
remain
use
identifi
caus
ard
examin
remain
inconclus
ct
scan
fundament
suspicion
intraabdomin
sepsi
case
pneumonia
ultrasonographi
import
evalu
biventricular
function
also
identifi
pleural
effus
pneumothorax
definit
ard
remain
clinic
main
object
diagnost
workup
focus
identif
aetiolog
especi
treatabl
infect
acut
respiratori
distress
syndrom
ard
defin
associ
bilater
infiltr
hypoxaemia
follow
initi
insult
new
definit
recent
propos
howev
one
consid
definit
lack
specif
recent
lungsaf
survey
show
ard
frequent
underdiagnos
clinician
consequ
protect
mechan
ventil
alway
implement
patient
identifi
ard
anoth
key
point
variou
form
ard
potenti
differ
regard
manag
ie
posit
endexpiratori
pressur
peep
set
prone
posit
use
neuromuscular
blockad
occasion
corticosteroid
furthermor
adequ
treatment
respons
caus
crucial
element
ard
outcom
common
risk
factor
associ
ard
follow
pneumonia
nonpulmonari
sepsi
aspir
gastric
content
major
trauma
pulmonari
contus
pancreat
inhal
injuri
sever
burn
noncardiogen
shock
drug
overdos
multipl
transfus
transfusionassoci
acut
lung
injuri
trali
pulmonari
vascul
drown
recent
improv
ard
outcom
mainli
relat
decreas
iatrogen
event
rather
specif
treatment
includ
limit
decreas
incid
ventilatorinduc
lung
injuri
reduc
use
sedat
reason
fluid
manag
improv
manag
infect
therefor
mandat
recogn
insult
caus
lung
injuri
better
adapt
aetiolog
treatment
symptomat
treatment
mainli
mechan
ventil
follow
section
identifi
prioriti
diagnost
procedur
identifi
caus
ard
improv
manag
pneumonia
lead
caus
ard
need
adequ
identifi
pathogen
respons
infect
bacteria
also
virus
parasit
fungi
caus
pneumonia
ard
also
import
consid
context
includ
local
epidemiolog
travel
histori
patient
recent
hospit
exposur
historysick
contact
immunocompet
thu
initi
diagnost
workup
ard
includ
systemat
microbiolog
assess
screen
potenti
pathogen
communityacquir
bacteri
pneumonia
frequent
caus
direct
injuri
lead
ard
bacteri
specif
usual
bacteri
caus
pneumonia
may
respons
ard
tabl
case
ard
develop
mechan
ventil
patient
nosocomi
pneumonia
consid
potenti
caus
aggrav
factor
virus
histor
held
respons
communityacquir
pneumonia
cap
case
influenza
frequent
howev
recent
studi
patient
sever
cap
requir
icu
admiss
found
use
polymeras
chain
reaction
pcr
rate
viru
recoveri
respiratori
tract
vast
major
respiratori
virus
tabl
virus
caus
sever
pneumonia
ard
best
diagnos
rtpcr
bronchoalveolar
lavag
besid
usual
respiratori
virus
herpesvirus
increas
recogn
caus
ard
tuxen
et
al
show
patient
ard
virolog
histolog
evid
herp
simplex
viru
hsv
tracheobronch
could
trigger
aggrav
factor
ard
recent
hsv
bronchopneumon
diagnos
nonimmunocompromis
patient
prolong
mechan
ventil
median
day
mechan
ventil
patient
develop
ard
diagnosi
made
hsvspecif
nuclear
inclus
observ
cell
recov
bronchoalveolar
lavag
bal
fluid
assess
viral
load
bal
threshold
cell
cytomegaloviru
cmv
also
wellrecogn
caus
nosocomi
pneumonia
nonimmunocompromis
icu
patient
could
associ
ard
hsv
cmv
could
reactiv
icu
patient
result
sepsisinduc
immunoparalysi
reactiv
asymptomat
patient
true
cmv
pneumonia
occur
patient
although
fungi
usual
caus
ard
pathogen
like
pneumocysti
jirovecii
toxoplasma
gondii
aspergillu
fumigatu
may
respons
ard
immunosuppress
patient
recogn
potenti
caus
ard
set
import
specif
treatment
could
chang
outcom
potenti
revers
infectioninduc
ard
physician
need
systemat
investig
infecti
aetiolog
initi
assess
patient
ard
includ
microbiolog
assess
look
wide
rang
pathogen
blood
cultur
urinari
antigen
test
legionella
pneumophila
serolog
test
intracellular
bacteria
ie
mycoplasma
pneumonia
chlamydia
pneumonia
legionella
pneumophila
microbi
sampl
lung
fibr
optic
bal
prefer
tool
ard
patient
allow
one
recov
larg
amount
intraalveolar
materi
although
minibronchoalveolar
lavag
accept
also
first
step
direct
microscop
examin
bal
fluid
allow
one
look
bacteria
use
gram
stain
also
use
giemsamodifi
stain
offer
number
advantag
gram
stain
includ
better
visual
host
cell
morpholog
includ
viral
cytopath
inclus
improv
detect
bacteria
particularli
intracellular
bacteria
detect
protozoan
fungal
pathogen
second
step
cultur
bacteria
use
quantit
cultur
bal
fluid
test
respiratori
virus
tabl
pneumocysti
fungi
aspergillu
use
pcr
see
tabl
moreov
specif
stain
immunostain
immunofluoresc
may
use
detect
legionella
pneumophila
pneumocysti
jirovecii
toxoplasma
gondii
pathogen
respons
pneumonia
immunocompet
immunosuppress
patient
fever
alert
clinician
inflammatori
process
infecti
noninfecti
origin
progress
fever
develop
ard
repres
difficult
diagnost
challeng
underscor
follow
first
clinic
criteria
limit
valu
identifi
pulmonari
extrapulmonari
sourc
infect
develop
ard
chest
xray
low
accuraci
set
second
develop
multipl
concurr
infecti
process
frequent
occurr
third
progress
pulmonari
fibroprolifer
alon
may
give
rise
fever
leukocytosi
clinic
indistinguish
nosocomi
pneumonia
therebi
make
clinic
distinct
infect
challeng
one
studi
deploy
extens
diagnost
protocol
identifi
sourc
fever
histolog
proven
fibroprolifer
sole
caus
ventilatorassoci
pneumonia
vap
final
viral
infect
may
also
caus
fever
set
hsv
cmv
reactiv
frequent
may
lead
lung
involv
ie
hsv
bronchopneumon
cmv
pneumonia
mimick
bacteri
diseas
diagnost
workup
ard
patient
develop
fever
thu
alway
firstli
rule
vap
bacteri
viral
secondli
rule
extrapulmonari
infect
thirdli
look
noninfecti
process
caus
recogn
ard
fibroprolifer
may
incrimin
caus
fever
set
bal
probabl
best
tool
allow
one
look
bacteria
virus
also
cytolog
histolog
difficult
case
patient
ard
decis
regard
site
bronchoscop
sampl
made
difficult
presenc
diffus
densiti
chest
radiograph
bilater
sampl
one
strategi
ard
patient
suspect
vap
diagnost
yield
bronchoscopi
evalu
bilater
bal
thirtythre
posit
bronchoscopi
signific
growth
one
side
right
bal
left
bal
howev
impact
strategi
regard
outcom
remain
valid
microbiolog
screen
also
includ
search
specif
microorgan
name
herpesvirida
hsv
cmv
reactiv
systemat
assess
viru
load
quantif
use
pcr
well
lung
involv
use
possibl
cytolog
criteria
viral
infect
howev
impact
antivir
treatment
regard
outcom
icu
patient
current
investig
prolong
methylprednisolon
treatment
use
patient
ard
blunt
febril
respons
physic
find
associ
inflamm
ie
abdomin
tender
therefor
infect
surveil
essenti
promptli
identifi
treat
nosocomi
infect
two
random
trial
incorpor
infect
surveil
includ
routin
bal
everi
day
intub
identifi
nosocomi
infect
absenc
fever
addit
vap
catheterrel
andor
bloodstream
infect
patient
might
risk
intraabdomin
infect
pancreat
sinc
find
may
mislead
appropri
clinic
set
comput
tomographi
abdomen
consid
patient
met
radiolog
clinic
criteria
berlin
definit
ard
none
risk
factor
recent
studi
shown
preval
ard
risk
factor
bal
fluid
cytolog
chest
ct
scan
specif
immunolog
examin
done
classic
risk
factor
found
druginduc
acut
respiratori
failur
also
consid
case
clinic
present
explain
malign
aetiolog
adenocarcinoma
lymphang
diagnosi
done
bal
cytolog
ct
scan
specif
biomark
instanc
role
open
lung
biopsi
order
identifi
malign
caus
respiratori
failur
fig
extens
demonstr
ard
often
secondari
disord
followsusu
within
ha
primari
diseas
associ
sever
system
inflamm
ard
system
inflamm
activ
nuclear
signal
system
potenti
downregul
activ
glucocorticoid
receptor
alpha
inflammatori
mediat
releas
system
circul
system
inflamm
primari
insult
reach
pulmonari
microcircul
lead
stereotyp
tissu
respons
consist
three
simultan
pathway
tissu
inflamm
haemostasi
intravascular
clot
extravascular
fibrin
deposit
hyalin
membran
tissu
repair
regener
nativ
parenchym
cell
fibroprolifer
deposit
extracellular
matrix
clinician
assess
progress
ard
daili
measur
variabl
incorpor
lung
injuri
score
li
simpl
physiolog
criteria
evolut
ard
divid
resolv
unresolv
basi
achiev
reduct
li
increas
pao
fio
mmhg
day
patient
unresolv
ard
contrast
resolv
ard
usual
histolog
evid
maladapt
lung
repair
fig
significantli
higher
morbid
mortal
shown
etabl
see
electron
supplementari
materi
measur
biomark
bal
well
concurr
plasma
sampl
demonstr
strong
caus
effect
relationship
persist
vs
reduct
system
pulmonari
inflammationfibroprolifer
progress
unresolv
vs
resolut
resolv
ard
respect
nonimprov
persist
elev
circul
bal
level
inflammatori
cytokin
chemokin
marker
lung
vascular
epitheli
permeabl
fibrogenesi
compar
improv
ard
patient
open
lung
biopsi
corticosteroid
potenti
indic
exhibit
sign
fibroprolifer
histolog
analysi
use
specif
biomark
pulmonari
fibrosi
may
use
earli
identif
popul
could
benefit
corticosteroid
serial
assess
ntermin
peptid
type
iii
procollagen
ntpcpiii
bal
blood
sampl
well
correl
clinic
outcom
recent
studi
report
alveolar
concentr
ntpcpiii
nonresolv
ard
patient
well
correl
presenc
lung
fibrosi
assess
histolog
examin
done
lung
biopsi
futur
studi
need
investig
use
biomark
guid
corticosteroid
treatment
patient
ard
landmark
descript
patient
acut
respiratori
distress
ashbaugh
et
al
report
variou
patholog
find
includ
limit
intraalveolar
haemorrhag
oedema
alveolar
atelectasi
macrophag
alveolar
space
engorg
capillari
autopsi
find
consist
find
presenc
hyalin
membran
hm
ard
patient
decad
later
katzenstein
bloor
liebow
defin
term
diffus
alveolar
damag
dad
manifest
injuri
alveolar
line
endotheli
cell
addit
hm
earli
chang
includ
capillari
congest
focal
intraalveolar
oedema
atelectasi
intraalveolar
haemorrhag
etabl
later
phase
dad
past
h
ventil
character
mononuclear
cell
infiltr
alveolar
space
alveolar
epitheli
cell
hyperplasia
signific
interstiti
fibrosi
case
ventil
day
clinic
syndrom
therefor
link
patholog
find
dad
hm
particular
howev
evid
histolog
featur
dad
becom
less
preval
modern
era
autopsi
studi
reveal
among
patient
risk
factor
ard
smaller
proport
met
patholog
criteria
hmposit
dad
time
period
compar
period
vs
p
tidal
volum
also
lower
recent
decad
even
patient
sever
ard
berlin
definit
demonstr
dad
autopsi
pneumonia
abund
neutrophil
domin
patholog
find
mani
clinic
defin
ard
case
dad
figur
provid
histolog
lung
exampl
ard
patient
without
hmposit
dad
understand
dad
patholog
hallmark
ard
skew
patholog
descript
ard
deriv
autopsi
find
know
littl
whether
patholog
find
dad
promin
milder
case
ard
patient
surviv
syndrom
prospect
observ
studi
open
lung
biopsi
patient
nonresolv
ard
without
clear
aetiolog
persist
day
shown
major
demonstr
fibrosi
consist
fibroprolif
stage
ard
howev
patient
proceed
biopsi
precis
caus
ard
appar
ard
increas
rate
nosocomi
infect
elev
level
inflammatori
cytokin
lung
favour
intraand
extracellular
growth
bacteri
pathogen
impair
opsonizationdepend
phagocyt
neutrophil
function
intracellular
kill
addit
morbid
attribut
elev
cytokinemia
includ
hyperglycaemia
shortand
longterm
neurolog
dysfunct
delirium
neuromuscular
weak
posttraumat
stress
disord
sudden
cardiac
event
underli
atherosclerosi
reproduc
permiss
prolong
thu
may
reflect
overal
popul
ard
conson
european
autopsi
studi
biopsi
frequent
disclos
infect
histolog
pattern
may
also
vari
depend
durat
ard
oedema
congest
becom
less
preval
day
syndrom
fibrosi
becom
preval
though
fibrosi
rel
rare
among
autopsydiagnos
ard
conclus
seem
unreason
conclud
patholog
evid
dad
gold
standard
ard
diagnosi
two
differ
situat
lung
histolog
could
use
diagnos
earli
cours
ard
curabl
aetiolog
result
less
invas
examin
bal
blood
sampl
ct
scan
inconclus
andor
toward
end
first
week
evolut
identifi
fibroprolifer
order
consid
corticosteroid
improv
outcom
absenc
concomit
nosocomi
infect
seri
surgic
lung
biopsi
nonresolv
ard
noncontribut
bal
presenc
fibrosi
report
case
addit
half
patient
fibrosi
concomit
infect
howev
import
note
signific
improv
microbiolog
diagnosi
infecti
pneumonia
use
bal
blood
sampl
biomark
fibroprolifer
ntpcpiii
measur
bal
also
demonstr
help
clinic
decisionmak
initi
corticosteroid
therefor
indic
remain
open
lung
biopsi
nonresolv
ard
current
clinic
practic
chest
xray
part
ard
definit
detail
elsewher
accuraci
exclud
review
lung
ct
scan
use
understand
pathophysiolog
interplay
mechan
ventil
ct
scan
clearli
show
ard
nonhomogen
lung
diseas
follow
classic
report
morpholog
pattern
consolid
region
defin
homogen
increas
densiti
without
vessel
bronchi
ground
glass
area
increas
densiti
still
recogniz
vessel
normal
aerat
region
three
morpholog
featur
usual
simultan
present
air
bronchogram
small
pleural
effus
also
common
depend
local
consolid
area
relat
increas
lung
oedema
ie
increas
lung
weight
initi
phase
ard
rais
hydrostat
pressur
transmit
throughout
lung
caus
reduct
lung
ga
volum
develop
nonaer
lung
region
poorli
nonaer
lung
region
character
higher
inflamm
normal
ventil
lung
region
presenc
noninfl
area
caus
major
expans
neighbour
lung
region
gener
higher
local
pressur
act
stress
raiser
higher
amount
inhomogen
accompani
higher
stress
raiser
sever
ard
wors
outcom
pulmonari
ard
present
fig
repres
patholog
two
patient
ard
postmortem
lung
examin
man
die
sever
influenza
confirm
pcr
day
lungprotect
ventil
histolog
demonstr
extens
hyalin
membran
arrow
evid
diffus
alveolar
damag
mononuclear
cell
infiltr
appar
loss
alveolar
epitheli
cell
b
repres
section
lung
biopsi
woman
moder
ard
day
extens
travel
histori
cultur
stain
neg
histori
demonstr
proteinrich
alveolar
oedema
haemorrhag
neutrophil
hyalin
membran
similar
amount
consolid
ground
glass
area
extrapulmonari
ard
higher
amount
ground
glass
area
howev
tri
diagnos
pulmonari
extrapulmonari
ard
basi
ct
find
accur
accord
lungprotect
strategi
higher
level
peep
may
indic
patient
sever
diseas
higher
amount
lung
oedema
recruit
unfortun
applic
peep
may
simultan
induc
inflat
expans
wellinfl
region
decreas
amount
poorli
nonaer
region
lung
recruit
thu
higher
peep
level
suggest
patient
higher
recruit
fig
avoid
unnecessari
higher
peep
level
patient
low
recruit
fig
way
ct
scan
use
describ
distribut
lung
opac
order
adapt
mechan
ventil
set
instanc
ct
scan
also
abl
identifi
unsuspect
pneumothorax
help
clinician
identifi
caus
ard
typic
lung
lesion
intraabdomin
process
caus
ard
howev
use
ct
scan
requir
transport
patient
radiolog
depart
use
ioniz
radiat
dedic
softwar
fig
repres
ct
scan
imag
two
patient
ard
patient
present
homogen
opac
high
potenti
recruit
b
patient
present
lung
inhomogen
low
potenti
recruit
h
work
complet
lung
ct
scan
quantit
comput
possibl
solut
includ
applic
low
dose
ct
scan
acquisit
protocol
abl
reduc
effect
dose
reduct
use
visual
anatom
analysi
classifi
suffici
sensit
specif
patient
basi
lung
recruit
recent
analys
ultrasonograph
artefact
produc
air
chest
wall
pleura
parenchyma
highlight
ultrasonographi
valuabl
tool
diagnosi
manag
ard
etabl
summar
exampl
normal
abnorm
find
seen
thorac
ultrasonographi
import
find
diagnosi
respiratori
failur
b
line
fig
defin
discret
laserlik
vertic
hyperecho
reverber
artefact
aris
pleural
line
extend
bottom
ultrasound
screen
without
fade
move
synchron
lung
slide
presenc
three
b
line
one
intercost
space
consid
abnorm
refer
b
pattern
shown
b
line
correl
interstiti
involv
lung
bpatternpredomin
lung
suggest
alveolar
process
ard
cardiogen
pulmonari
oedema
unilater
pneumonia
rather
nonalveolar
caus
airway
obstruct
diseas
vascular
disord
howev
presenc
bilater
b
pattern
per
se
differenti
ard
cardiogen
pulmonari
oedema
aetiolog
alveolar
process
ultrasonograph
characterist
nonhomogen
distribut
b
pattern
pleural
line
abnorm
absent
reduc
lung
slide
thicken
irregular
c
consolid
pattern
observ
commonli
ard
compar
cardiogen
pulmonari
oedema
combin
cardiac
thorac
ultrasonographi
abl
help
differenti
ard
aetiolog
acut
respiratori
failur
ard
cardiogen
pulmonari
oedema
present
bpatternpredomin
lung
shown
left
pleural
effus
moder
sever
decreas
left
ventricular
function
larg
inferior
vena
cava
minim
diamet
help
identifi
cardiogen
pulmonari
oedema
compar
ard
acut
hypoxaem
patient
tabl
summar
common
ultrasonograph
find
ard
cardiogen
pulmonari
oedema
sequenti
thorac
ultrasonographi
use
monitor
lung
parenchym
chang
diagnosi
ard
sudden
sever
haemodynam
andor
respiratori
chang
suggest
presenc
pneumothorax
studi
suggest
evolut
ard
vap
could
also
success
follow
time
thorac
ultrasonographi
measur
ultrasound
lung
reaerat
score
base
ultrasonograph
find
applic
peep
could
reliabl
pressurevolum
curv
method
assess
lung
recruit
summari
ultrasonographi
role
diagnosi
manag
ard
portabl
noninvas
lack
radiat
make
bedsid
ultrasonographi
attract
adjunct
tool
physic
examin
laboratori
data
imag
studi
importantli
new
noninvas
promis
techniqu
electr
imped
tomographi
may
contribut
diagnos
region
inhomogen
lung
recruit
technolog
improv
would
contribut
increas
accuraci
asthma
mani
type
cancer
identif
subphenotyp
diseas
distinct
clinic
biolog
featur
differ
natur
histori
differenti
respons
therapyalso
known
endotyp
dramat
advanc
research
clinic
care
past
sever
year
increas
evid
distinct
subphenotyp
ard
classifi
sever
biolog
aetiolog
time
radiograph
appear
combin
thereof
clinician
attempt
incorpor
phenotyp
identif
bedsid
futur
year
perhap
bestaccept
longeststand
approach
subphenotyp
patient
ard
sever
oxygen
impair
ie
pao
fio
ratio
simpl
practic
approach
incorpor
origin
newer
berlin
definit
ard
focus
moderatesever
ard
clinic
trial
led
notabl
success
includ
recent
posit
trial
neuromuscular
blockad
prone
posit
signific
impact
clinic
practic
anoth
approach
identif
distinct
ard
subtyp
begin
clinic
evid
subgroupseg
traumarel
ard
vs
sepsisrel
ard
direct
vs
indirect
lung
injuryand
ask
whether
subgroup
differ
biomark
diseas
differ
histopatholog
differ
clinic
outcom
approach
yield
import
insight
highlight
clinic
biolog
heterogen
within
ard
exampl
patient
ard
direct
pulmonari
caus
eg
pneumonia
aspir
biomark
profil
reflect
sever
lung
epitheli
injuri
patient
indirect
ard
eg
nonpulmonari
sepsi
biomark
evid
sever
endotheli
injuri
inflamm
likewis
seri
eleg
studi
patient
diffus
ard
chest
comput
tomographi
lower
lung
complianc
better
respons
peep
higher
level
receptor
advanc
glycat
endproduct
rage
marker
lung
epitheli
injuri
inflamm
compar
patient
focal
ard
yet
anoth
promis
approach
adapt
wellestablish
statist
method
identifi
meaning
subgroup
within
ard
free
presupposit
subgroup
might
appli
latent
class
model
two
larg
random
control
trial
sampl
ard
patient
investig
found
strong
evid
cohort
two
distinct
endotyp
ard
hyperinflammatori
endotyp
hypoinflammatori
endotyp
two
endotyp
differ
clinic
biolog
featur
wide
diverg
clinic
outcom
perhap
importantli
differenti
respons
randomli
assign
treatment
higher
vs
lower
peep
anoth
group
investig
use
similar
approach
analys
data
time
ard
patient
sever
trauma
found
evid
earli
late
ard
subtyp
well
evid
biolog
differ
two
group
moment
clinic
impact
ard
phenotyp
identif
hing
whether
divis
ard
specif
subphenotyp
improv
clinic
outcom
assess
sever
ard
use
pao
fio
ratio
alreadi
import
implic
clinic
practic
care
consid
patient
propos
subphenotyp
ard
question
clinic
impact
remain
open
studi
ongo
determin
patient
diffus
versu
focal
ard
respond
differ
random
control
trial
mechan
ventil
practic
hyperand
hypoinflammatori
subtyp
respond
differ
randomli
assign
therapi
peep
obviou
caus
ard
direct
lung
injuri
suspect
bronchoscop
bal
minib
pivot
examin
order
identifi
microorgan
respons
pneumonia
routin
cultur
pcr
cytolog
direct
examin
blood
sampl
also
help
identifi
microorgan
evalu
biomark
infect
infecti
caus
ard
appar
aetiolog
secondlin
examin
includ
common
marker
immunolog
diseas
select
instanc
open
lung
biopsi
remain
use
identifi
caus
ard
previou
examin
remain
inconclus
ct
scan
fundament
examin
suspicion
intraabdomin
sepsi
agent
pneumonia
aspergillosi
suspect
although
role
ct
scan
adjust
ventil
set
routin
use
object
recommend
ultrasonographi
import
evalu
left
right
ventricular
function
also
help
identifi
pleural
effus
presenc
pneumothorax
presenc
nonresolv
ard
secondari
deterior
respiratori
statu
bal
blood
sampl
use
identifi
microorgan
may
respons
vap
may
also
use
evalu
biomark
indic
fibroprolifer
context
open
lung
biopsi
indic
reason
suspicion
undiagnos
infect
anoth
process
masquerad
ard
malign
immunolog
disord
ard
phenotyp
identif
sort
ard
specif
subphenotyp
could
improv
clinic
outcom
ongo
futur
studi
attempt
assess
latter
topic
onlin
version
articl
contain
supplementari
materi
avail
author
user
materi
provid
dr
meduri
result
work
support
resourc
use
facil
memphi
va
medic
center
content
repres
view
us
depart
veteran
affair
us
govern
none
